Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E
(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects
Kelly AS, Metzig AM, Rudser KD, Fitch AK, Fox CK, Nathan BM, et al
These antioxidants team up well
Zoom In : Adults with obesity who received MariTide lost up to 20% of their body weight over 52 weeks